blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1059843

EP1059843 - METHOD FOR DECREASING QT DISPERSION OR INHIBITING THE PROGRESSION OF QT DISPERSION WITH AN ANGIOTENSIN II RECEPTOR ANTAGONIST [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  24.10.2003
Database last updated on 16.07.2024
Most recent event   Tooltip24.10.2003Withdrawal of applicationpublished on 10.12.2003  [2003/50]
Applicant(s)For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
[N/P]
Former [2000/51]For all designated states
MERCK & CO., INC.
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
Inventor(s)01 / DECKELBAUM, Lawrence, I.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
02 / SEGAL, Robert
126 East Lincoln Avenue
Rahway, NJ 07065 / US
03 / ROBINSON, Paul J.
Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
[2000/51]
Representative(s)Hiscock, Ian James, et al
European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
[N/P]
Former [2000/51]Hiscock, Ian James, et al
European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date99936018.322.02.1999
[2000/51]
WO1999US03828
Priority number, dateUS19980075915P25.02.1998         Original published format: US 75915 P
GB1998000893727.04.1998         Original published format: GB 9808937
[2000/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9943210
Date:02.09.1999
Language:EN
[1999/35]
Type: A1 Application with search report 
No.:EP1059843
Date:20.12.2000
Language:EN
The application published by WIPO in one of the EPO official languages on 02.09.1999 takes the place of the publication of the European patent application.
[2000/51]
Search report(s)International search report - published on:US02.09.1999
ClassificationIPC:A01N43/56, A61K31/415
[2000/51]
CPC:
A61K31/415 (EP,US); A61K31/00 (EP,US); A61P43/00 (EP);
A61P9/00 (EP); A61P9/06 (EP); A61P9/10 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [2000/51]
Extension statesAL25.09.2000
LT25.09.2000
LV25.09.2000
MK25.09.2000
RO25.09.2000
SI25.09.2000
TitleGerman:VERFAHREN ZUR VERMINDERUNG DER QT DISPERSION ODER ZUR INHIBIERUNG DER PROGRESSION DER QT DISPERSION MIT EINEM ANGIOTENSIN II REZEPTOR ANTAGONISTEN[2000/51]
English:METHOD FOR DECREASING QT DISPERSION OR INHIBITING THE PROGRESSION OF QT DISPERSION WITH AN ANGIOTENSIN II RECEPTOR ANTAGONIST[2000/51]
French:PROCEDE DE REDUCTION DE L'ALLONGEMENT DE L'ESPACE QT OU D'INHIBITION DE L'ALLONGEMENT DE L'ESPACE QT A L'AIDE D'UN ANTAGONISTE DE RECEPTEUR DE L'ANGIOTENSINE II[2000/51]
Entry into regional phase25.09.2000National basic fee paid 
25.09.2000Search fee paid 
25.09.2000Designation fee(s) paid 
25.09.2000Examination fee paid 
Examination procedure14.09.1999Request for preliminary examination filed
International Preliminary Examining Authority: US
25.09.2000Examination requested  [2000/51]
17.10.2003Application withdrawn by applicant  [2003/50]
Fees paidRenewal fee
28.02.2001Renewal fee patent year 03
28.02.2002Renewal fee patent year 04
06.02.2003Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP0577023  ;
 [X]  - STN WPIDS, (19000101), Database accession no. 94-009332/02, XP002920522 & EP0577023 A2 00000000
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.